BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7940791)

  • 1. Impact of cyclosporine on chronic rejection and graft vasculopathy.
    Vanrenterghem Y; Peeters J
    Transplant Proc; 1994 Oct; 26(5):2560-3. PubMed ID: 7940791
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
    Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
    Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
    [No Abstract]   [Full Text] [Related]  

  • 3. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 5. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 6. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin monotherapy in pancreaticorenal transplantation.
    Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
    Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
    [No Abstract]   [Full Text] [Related]  

  • 9. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
    Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
    Mihatsch MJ; Ryffel B; Gudat F
    Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants.
    Reinsmoen NL; Hertz MI; Kubo S; Bolman RM; Matas AJ
    Transplant Proc; 1993 Dec; 25(6):3277-8. PubMed ID: 8266541
    [No Abstract]   [Full Text] [Related]  

  • 15. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 16. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance.
    Kim HC; Park SB; Lee SH; Park KK; Park CH; Cho WH
    Transplant Proc; 1994 Aug; 26(4):2134-5. PubMed ID: 8066696
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 19. Kidney transplantation in pediatric population.
    Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
    Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.